Jan 15, 2026
Ruben F. Salinas and Greg Kunst on the hidden epidemic of chronic ocular pain
Jan 08, 2026
EyeCool Therapeutics Announces Encouraging Interim Clinical Results for ETX-4143 in Chronic Ocular Surface Pain
Sept 02, 2025
EyeCool Therapeutics Appoints Dr. Vance Thompson to Board of Directors
May 07, 2025
EyeCool Therapeutics Announces Promising Results from Double-Masked Randomized Controlled Trial in Chronic Ocular Surface Pain (COSP)
